Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ayako Iida-Ueno"'
Autor:
Masaru Enomoto, Atsushi Hagihara, Akihiro Tamori, Ayako Iida-Ueno, Yuga Amano-Teranishi, Minh Phuong Dong, Dinh Viet Hoang, Le Thi Thanh Thuy, Norifumi Kawada, Sawako Uchida-Kobayashi, Hoang Hai, Naoshi Odagiri, Hideki Fujii, Vu Ngoc Hieu
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
In hepatocellular carcinoma (HCC), the clinical significance of soluble immune checkpoint protein levels as predictors of patient outcomes or therapeutic responses has yet to be defined. This study profiled the baseline levels of sixteen soluble chec
Autor:
Yoshiki Murakami, Hiroyasu Morikawa, Akihiro Tamori, Masaru Enomoto, Yuga Teranishi, Ayako Iida-Ueno, Le Thi Thanh Thuy, Atsushi Hagihara, Norifumi Kawada, Sawako Uchida-Kobayashi, Hideki Fujii
Publikováno v:
Cancer Chemotherapy and Pharmacology. 82:857-864
This study aimed to identify a biomarker for predicting the response to sorafenib in patients with hepatocellular carcinoma (HCC). Of 100 patients with unresectable HCC who received sorafenib treatment in our institute (Cohort A), 48 had stored plasm
Publikováno v:
Journal of medical virology. 91(7)
No controlled trial in patients with chronic hepatitis B virus (HBV) infection on long-term entecavir (ETV) treatment, comparing switching to tenofovir disoproxil fumarate (TDF) with continuing the therapy, has been reported. Twenty-seven nucleos(t)i
Autor:
Hiroyasu Morikawa, Sawako Uchida-Kobayashi, Hirotaka Ishizu, Norifumi Kawada, Ayako Iida-Ueno, Etsushi Kawamura, Hiroyuki Motoyama, Sayuri Takada, Masaru Enomoto, Yuga Teranishi, Ritsuzo Kozuka, Akihiro Tamori, Atsushi Hagihara, Yoshiki Murakami
Publikováno v:
Kanzo. 57:328-333
Autor:
Hiroyasu Morikawa, Hideki Fujii, Atsushi Hagihara, Sawako Uchida-Kobayashi, Ayako Iida-Ueno, Akihiro Tamori, Norifumi Kawada, Etsushi Kawamura, Hiroyuki Motoyama, Yoshiki Murakami, Masaru Enomoto, Ritsuzo Kozuka
Publikováno v:
Kanzo. 57:7-16
Publikováno v:
World Journal of Gastroenterology
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and the second most common cause of cancer deaths worldwide. The top three causes of HCC are hepatitis B virus (HBV), hepatitis C virus (HCV), and alcoholic liver disease
Autor:
Iida-Ueno A; Ayako Iida-Ueno, Masaru Enomoto, Akihiro Tamori, Norifumi Kawada, Department of Hepatology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan., Enomoto M; Ayako Iida-Ueno, Masaru Enomoto, Akihiro Tamori, Norifumi Kawada, Department of Hepatology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan., Tamori A; Ayako Iida-Ueno, Masaru Enomoto, Akihiro Tamori, Norifumi Kawada, Department of Hepatology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan., Kawada N; Ayako Iida-Ueno, Masaru Enomoto, Akihiro Tamori, Norifumi Kawada, Department of Hepatology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Publikováno v:
World journal of gastroenterology [World J Gastroenterol] 2017 Apr 21; Vol. 23 (15), pp. 2651-2659.